Pancreatic Cancer Research

ResearcherUniversity of MichiganActive in the last 2 years

Matthew T. McMillan

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-1172-9273; OpenAlex author ID A5061777265. Sources: OpenAlex.

Their work

Papers
2 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2022: 1 paper · 2023: none · 2024: none · 2025: 1 paper

Papers 2

  1. Advances in Vaccine-Based Therapies for Pancreatic Cancer. Co-author DOI 10.1007/s12029-025-01165-4↗
  2. DNA-PK Inhibition and Radiation Promote Antitumoral Immunity through RNA Polymerase III in Pancreatic Cancer. First author DOI 10.1158/1541-7786.mcr-21-0725↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Kevin C. Soares · 1 shared paper, 2025 · strength 0.54
  2. Leslie A. Parsels · 1 shared paper, 2022 · strength 0.13
  3. Theodore Steven Lawrence · 1 shared paper, 2022 · strength 0.13
  4. Meredith Ann Morgan · 1 shared paper, 2022 · strength 0.13
  5. Qiang Zhang · 1 shared paper, 2022 · strength 0.13
  6. David M. Karnak · 1 shared paper, 2022 · strength 0.13
  7. Timothy L. Frankel · 1 shared paper, 2022 · strength 0.13
  8. Weiwei Wang · 1 shared paper, 2022 · strength 0.13

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.